Skip to main content
. 2019 Jan 16;13:892. doi: 10.3332/ecancer.2019.892

Table 2. Oncological outcomes.

Oncological outcomes (n = 299)
CR 228 76.25% of total
NR 65 21.7% of total
SD 33 50.8% of NR
PD 32 49.2% of NR
PR 7 2.3% of total
Relapse 77 33.8% of CR